Davion Healthcare Enters Into Non-Exclusive Financial Advisory Agreement With Vienna Capital To Support Proposed $100M-Plus Acquisition Financing Strategy For 2027

Davion Healthcare Plc (NASDAQ:DAVI) ("Davion" or the "Company"), a developer of non-invasive health monitoring technologies, announces that it has entered into a non-exclusive financial advisory agreement with Vienna Capital Partners LLC ("Vienna Capital"), a New York-based financial services firm, to support its proposed US$100 million-plus acquisition financing strategy for 2027.

The appointment forms part of Davion’s strategy to build a diversified healthcare and related services group through the acquisition of established, profitable and cash-generative businesses, principally in the United States. It follows the Company’s recent announcement of its proposed $13.5 million acquisition of Healthcare Stat Homecare Inc., a profitable US home healthcare business.

Under the agreement, Vienna Capital will advise Davion on institutional financing structures and potential funding arrangements to support its acquisition program. The Company intends to focus principally on senior secured, non-convertible debt financing from institutional lenders, private credit providers and other financial institutions, with the objective of supporting acquisitions while minimizing equity dilution for existing shareholders.